7Baggers

We provide you with 20 years of free, institutional-grade data for IRON stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of IRON. Explore the full financial landscape of IRON stock.

Reported DateCIKTickerType
2025-08-071816736IRON10-QUrl
2025-05-071816736IRON10-QUrl
2025-02-271816736IRON10-KUrl
2024-11-121816736IRON10-QUrl
2024-08-081816736IRON10-QUrl
2024-05-091816736IRON10-QUrl
2024-03-211816736IRON10-KUrl
2023-11-091816736IRON10-QUrl
2023-08-111816736IRON10-QUrl
2023-05-151816736IRON10-QUrl
2023-03-311816736IRON10-KUrl
2022-11-101816736IRON10-QUrl
2022-08-111816736IRON10-QUrl
2022-05-061816736IRON10-QUrl
2022-03-101816736IRON10-KUrl
2021-11-151816736IRON10-QUrl
2021-08-121816736IRON10-QUrl
2021-05-131816736IRON10-QUrl
2021-03-291816736IRON10-KUrl
2021-02-171816736IRONS-1Url
2020-11-121816736IRON10-QUrl
2020-07-241816736IRONS-1Url

Disc Medicine Inc.
(NASDAQ:IRON) 

IRON stock logo

Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The company is headquartered in Watertown, Massachusetts.

Founded: 2017
CEO: John Quisel  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
The information provided in this report about IRON stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.